{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:18:42Z","timestamp":1787062722820,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01174-w","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:14:00Z","timestamp":1771931640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Peripheral blood immune cell subsets as non-invasive biomarkers of colorectal cancer stage, laterality, metastasis and survival"],"prefix":"10.1007","volume":"49","author":[{"given":"Julia","family":"del Prado-Montero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Cantero-Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Guevara-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Lozano-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Cueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"S\u00e1enz de Santa Mar\u00eda-Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Terr\u00f3n-Arcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Abad-Moret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"D\u00edaz-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"C\u00f3rdoba-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Fern\u00e1ndez-Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Montalb\u00e1n-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"del Fresno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hurtado-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"L\u00f3pez-Collazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"3","key":"1174_CR1","first-page":"229","volume":"74","author":"F. Bray","year":"2024","unstructured":"F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer. J. Clinicians. 74(3), 229\u2013263 (2024, May)","journal-title":"CA Cancer J Clinicians"},{"issue":"7","key":"1174_CR2","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cancers14071732","volume":"14","author":"H. MdS","year":"2022","unstructured":"H. MdS, H. Karuniawati, A.A. Jairoun, Z. Urbi, D.J. Ooi, A. John et al., Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers. 14(7), 1732 (2022, Mar 29)","journal-title":"Cancers"},{"key":"1174_CR3","doi-asserted-by":"publisher","first-page":"175628482091752","DOI":"10.1177\/1756284820917527","volume":"13","author":"G. Golshani","year":"2020","unstructured":"G. Golshani, Y. Zhang, Advances in immunotherapy for colorectal cancer: a review. Therap. Adv. Gastroenterol. 13, 1756284820917527 (2020, Jan)","journal-title":"Therap Adv Gastroenterol"},{"key":"1174_CR4","unstructured":"CRC Colon [Internet]. [cited 2025 May 26]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer#:%7E:text=The%20incidence%20rates%20were%20highest,an%20increase%20of%2073%25"},{"issue":"10","key":"1174_CR5","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y. Xi","year":"2021","unstructured":"Y. Xi, P. Xu, Global colorectal cancer burden in 2020 and projections to 2040. Transl. Oncol. 14(10), 101174 (2021, Oct)","journal-title":"Transl. Oncol."},{"issue":"2","key":"1174_CR6","first-page":"104","volume":"64","author":"R. Siegel","year":"2014","unstructured":"R. Siegel, C. DeSantis, A. Jemal, Colorectal cancer statistics, 2014. CA. Cancer. J. Clinicians. 64(2), 104\u2013117 (2014, Mar)","journal-title":"CA Cancer J Clinicians"},{"issue":"8","key":"1174_CR7","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/annonc\/mdt157","volume":"24","author":"K. Garborg","year":"2013","unstructured":"K. Garborg, \u00d8. Holme, M. L\u00f8berg, M. Kalager, H.O. Adami, M. Bretthauer, Current status of screening for colorectal cancer. Ann. Oncol. 24(8), 1963\u20131972 (2013, Aug)","journal-title":"Ann. Oncol."},{"issue":"4","key":"1174_CR8","first-page":"372","volume":"72","author":"F. Ciardiello","year":"2022","unstructured":"F. Ciardiello, D. Ciardiello, G. Martini, S. Napolitano, J. Tabernero, A. Cervantes, Clinical management of metastatic colorectal cancer in the era of precision medicine. CA. Cancer. J. Clinicians. 72(4), 372\u2013401 (2022, Jul)","journal-title":"CA Cancer J Clinicians"},{"issue":"2","key":"1174_CR9","first-page":"208","volume":"6","author":"J.L. Markman","year":"2015","unstructured":"J.L. Markman, S.L. Shiao, Impact of the immune system and immunotherapy in colorectal cancer. J. Gastrointest. Oncol. 6(2), 208\u2013223 (2015, Apr)","journal-title":"J Gastrointest Oncol"},{"issue":"4","key":"1174_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.14740\/gr1062w","volume":"11","author":"B. Baran","year":"2018","unstructured":"B. Baran, N. Mert Ozupek, N. Yerli Tetik, E. Acar, O. Bekcioglu, Y. Baskin, Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterol. Res. 11(4), 264\u2013273 (2018)","journal-title":"Gastroenterol Res"},{"issue":"1","key":"1174_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-025-02327-5","volume":"24","author":"H.J. Boka","year":"2025","unstructured":"H.J. Boka, R.M. Engel, C. Georges, P.J. McMurrick, H.E. Abud, Does side matter? Deciphering mechanisms that underpin side-dependent pathogenesis and therapy response in colorectal cancer. Mol. Cancer. 24(1), 130 (2025, May 2)","journal-title":"Mol Cancer"},{"issue":"1","key":"1174_CR12","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1038\/s41598-024-55139-w","volume":"14","author":"I. Ciepiela","year":"2024","unstructured":"I. Ciepiela, M. Szczepaniak, P. Ciepiela, K. Hi\u0144cza-Nowak, J. Kopczy\u0144ski, P. Macek et al., Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients. Sci. Rep. 14(1), 4619 (2024, Feb 26)","journal-title":"Sci Rep"},{"issue":"4","key":"1174_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrclinonc.2011.15","volume":"8","author":"S. Van Schaeybroeck","year":"2011","unstructured":"S. Van Schaeybroeck, W.L. Allen, R.C. Turkington, P.G. Johnston, Implementing prognostic and predictive biomarkers in CRC clinical trials. Nat. Rev. Clin. Oncol. 8(4), 222\u2013232 (2011, Apr)","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"1174_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.bjc.6605164","volume":"101","author":"J. Souglakos","year":"2009","unstructured":"J. Souglakos, J. Philips, R. Wang, S. Marwah, M. Silver, M. Tzardi et al., Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br. J. Cancer. 101(3), 465\u2013472 (2009, Aug)","journal-title":"Br J Cancer"},{"issue":"3","key":"1174_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"C.M. Ribic","year":"2003","unstructured":"C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French, R.M. Goldberg et al., Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 349(3), 247\u2013257 (2003, Jul 17)","journal-title":"N Engl J Med"},{"key":"1174_CR16","doi-asserted-by":"crossref","unstructured":"D.S. Vinay, E.P. Ryan, G. Pawelec, W.H. Talib, J. Stagg, E. Elkord et al., Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin. Cancer Biol. 35, S185\u201398 (2015, Dec)","DOI":"10.1016\/j.semcancer.2015.03.004"},{"issue":"20","key":"1174_CR17","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1158\/1078-0432.CCR-09-1438","volume":"15","author":"S. Ogino","year":"2009","unstructured":"S. Ogino, K. Nosho, N. Irahara, J.A. Meyerhardt, Y. Baba, K. Shima et al., Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node Count, microsatellite instability, and CpG island methylator phenotype. Clin. Cancer. Res. 15(20), 6412\u20136420 (2009, Oct 15)","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"1174_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","volume":"29","author":"B. Mlecnik","year":"2011","unstructured":"B. Mlecnik, M. Tosolini, A. Kirilovsky, A. Berger, G. Bindea, T. Meatchi et al., Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. JCO. 29(6), 610\u2013618 (2011, Feb 20)","journal-title":"JCO"},{"issue":"16","key":"1174_CR19","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","volume":"14","author":"K.I. Al-Shibli","year":"2008","unstructured":"K.I. Al-Shibli, T. Donnem, S. Al-Saad, M. Persson, R.M. Bremnes, L.T. Busund, Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin. Cancer. Res. 14(16), 5220\u20135227 (2008, Aug 15)","journal-title":"Clin. Cancer Res."},{"key":"1174_CR20","unstructured":"M.F.D. Oliveira, J.P. Romero, M. Chung, S.R. Williams, A.D. Gottscho, A. Gupta et al., High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat Genet [Internet]. 2025, Jun 5). cited 2025 Jun 12]; Available from: https:\/\/www.nature.com\/articles\/s41588-025-02193-3"},{"key":"1174_CR21","doi-asserted-by":"publisher","first-page":"978862","DOI":"10.3389\/fimmu.2022.978862","volume":"13","author":"Z.A. Bazzi","year":"2023","unstructured":"Z.A. Bazzi, S. Sneddon, P.G.Y. Zhang, I.T. Tai, Characterization of the immune cell landscape in CRC: clinical implications of tumour-infiltrating leukocytes in early- and late-stage CRC. Front. Immunol. 13, 978862 (2023, Feb 8)","journal-title":"Front Immunol"},{"issue":"1","key":"1174_CR22","doi-asserted-by":"publisher","first-page":"18166","DOI":"10.1038\/s41598-022-23190-0","volume":"12","author":"L. Zhang","year":"2022","unstructured":"L. Zhang, X. Chen, S. Zu, Y. Lu, Characteristics of circulating adaptive immune cells in patients with colorectal cancer. Sci. Rep. 12(1), 18166 (2022, Oct 28)","journal-title":"Sci Rep"},{"issue":"8","key":"1174_CR23","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P. Sharma","year":"2023","unstructured":"P. Sharma, S. Goswami, D. Raychaudhuri, B.A. Siddiqui, P. Singh, A. Nagarajan et al., Immune checkpoint therapy-current perspectives and future directions. Cell. 186(8), 1652\u20131669 (2023, Apr)","journal-title":"Cell"},{"issue":"3","key":"1174_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"J.J. Havel","year":"2019","unstructured":"J.J. Havel, D. Chowell, T.A. Chan, The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat. Rev. Cancer. 19(3), 133\u2013150 (2019, Mar)","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1174_CR25","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.3390\/jcm11123287","volume":"11","author":"R. Lozano-Rodr\u00edguez","year":"2022","unstructured":"R. Lozano-Rodr\u00edguez, V. Terr\u00f3n-Arcos, R. L\u00f3pez, J. Mart\u00edn-Guti\u00e9rrez, A. Mart\u00edn-Quir\u00f3s, C. Maroun-Eid et al., Differential immune checkpoint and Ig-like V-Type receptor profiles in COVID-19: associations with severity and treatment. JCM. 11(12), 3287 (2022, Jun 8)","journal-title":"JCM"},{"issue":"2","key":"1174_CR26","doi-asserted-by":"publisher","first-page":"110235","DOI":"10.1016\/j.celrep.2021.110235","volume":"38","author":"R. Lozano-Rodr\u00edguez","year":"2022","unstructured":"R. Lozano-Rodr\u00edguez, J. Valent\u00edn-Quiroga, J. Avenda\u00f1o-Ortiz, A. Mart\u00edn-Quir\u00f3s, A. Pascual-Iglesias, V. Terr\u00f3n-Arcos et al., Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19. Cell. Rep. 38(2), 110235 (2022, Jan)","journal-title":"Cell. Rep."},{"key":"1174_CR27","doi-asserted-by":"crossref","unstructured":"M. Mauri, T. Elli, G. Caviglia, G. Uboldi, M. Azzi, 2017 Rawgraphs: a visualisation platform to create open outputs, in Proceedings of the 12th Biannual Conference on Italian SIGCHI Chapter [Internet], pp. 1\u20135. Available from: ACM, Cagliari Italy. cited 2025 Jul 31: https:\/\/dl.acm.org\/doi\/10.1145\/3125571.3125585","DOI":"10.1145\/3125571.3125585"},{"issue":"1","key":"1174_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13046-025-03337-3","volume":"44","author":"P. Mata-Mart\u00ednez","year":"2025","unstructured":"P. Mata-Mart\u00ednez, L. Celada, F.J. Cueto, G. S\u00e1enz De Santa Mar\u00eda, J. Fern\u00e1ndez, V. Terr\u00f3n-Arcos et al., A blood-based liquid biopsy analyzing soluble immune checkpoints and cytokines identifies distinct neuroendocrine tumors. J. Exp. Clin. Cancer. Res. 44(1), 82 (2025, Mar 5)","journal-title":"J Exp Clin Cancer Res"},{"key":"1174_CR29","doi-asserted-by":"crossref","unstructured":"J. Avenda\u00f1o-Ortiz, R. Lozano-Rodr\u00edguez, A. Mart\u00edn-Quir\u00f3s, V. Terr\u00f3n, C. Maroun-Eid, K. Montalb\u00e1n-Hern\u00e1ndez et al., The immune checkpoints storm in COVID-19: role as severity markers at emergency department admission. Clin. Transl. Med. 11(10), e573 (2021, Oct)","DOI":"10.1002\/ctm2.573"},{"issue":"3","key":"1174_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1615\/CritRevImmunol.v29.i3.10","volume":"29","author":"W.L. Redmond","year":"2009","unstructured":"W.L. Redmond, C.E. Ruby, A.D. Weinberg, The role of OX40-mediated co-stimulation in T-cell activation and survival. Crit. Rev. Immunol. 29(3), 187\u2013201 (2009)","journal-title":"Crit Rev Immunol"},{"issue":"10","key":"1174_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41416-020-0810-1","volume":"122","author":"H. Ohmura","year":"2020","unstructured":"H. Ohmura, K. Yamaguchi, F. Hanamura, M. Ito, A. Makiyama, K. Uchino et al., OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody. Br. J. Cancer. 122(10), 1507\u20131517 (2020, May 12)","journal-title":"Br J Cancer"},{"issue":"4","key":"1174_CR32","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.4049\/jimmunol.176.4.2397","volume":"176","author":"D. Pozo","year":"2006","unstructured":"D. Pozo, M. Val\u00e9s-G\u00f3mez, N. Mavaddat, S.C. Williamson, S.E. Chisholm, H. Reyburn, CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase. The J. Immunol. 176(4), 2397\u20132406 (2006, Feb 15)","journal-title":"The J Immunol"},{"issue":"3","key":"1174_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.celrep.2014.09.045","volume":"9","author":"J.R. Fergusson","year":"2014","unstructured":"J.R. Fergusson, K.E. Smith, V.M. Fleming, N. Rajoriya, E.W. Newell, R. Simmons et al., CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell. Rep. 9(3), 1075\u20131088 (2014, Nov 6)","journal-title":"Cell. Rep."},{"issue":"2","key":"1174_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/mi.2008.84","volume":"2","author":"C. Wang","year":"2009","unstructured":"C. Wang, S.G. Kang, J. Lee, Z. Sun, C.H. Kim, The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal. Immunol. 2(2), 173\u2013183 (2009, Mar)","journal-title":"Mucosal Immunol"},{"issue":"45","key":"1174_CR35","doi-asserted-by":"publisher","first-page":"72961","DOI":"10.18632\/oncotarget.12150","volume":"7","author":"A. Beldi-Ferchiou","year":"2016","unstructured":"A. Beldi-Ferchiou, M. Lambert, S. Dogniaux, F. V\u00e9ly, E. Vivier, D. Olive et al., PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma. Oncotarget. 7(45), 72961\u201372977 (2016, Nov 8)","journal-title":"Oncotarget"},{"issue":"6","key":"1174_CR36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00262-019-02343-7","volume":"68","author":"D. Krijgsman","year":"2019","unstructured":"D. Krijgsman, N.L. de Vries, A. Skovbo, M.N. Andersen, M. Swets, E. Bastiaannet et al., Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Cancer. Immunol. Immunother. 68(6), 1011\u20131024 (2019, Jun)","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"1174_CR37","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00262-022-03337-8","volume":"72","author":"M.A. Al-Mterin","year":"2023","unstructured":"M.A. Al-Mterin, K. Murshed, E. Elkord, PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-na\u00efve CRC patients. Cancer. Immunol. Immunother. 72(6), 1933\u20131939 (2023, Jun)","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"1174_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12032-019-1307-8","volume":"36","author":"F. Cui","year":"2019","unstructured":"F. Cui, D. Qu, R. Sun, K. Nan, Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapy. Med. Oncol. 36(10), 84 (2019, Sep 6)","journal-title":"Med Oncol"},{"issue":"9","key":"1174_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1158\/2326-6066.CIR-16-0193","volume":"4","author":"G. Plitas","year":"2016","unstructured":"G. Plitas, A.Y. Rudensky, Regulatory T cells: differentiation and function. Cancer. Immunol. Res. 4(9), 721\u2013725 (2016, Sep 2)","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"1174_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","volume":"24","author":"T.S. Sumida","year":"2024","unstructured":"T.S. Sumida, N.T. Cheru, D.A. Hafler, The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat. Rev. Immunol. 24(7), 503\u2013517 (2024, Jul)","journal-title":"Nat Rev Immunol"},{"issue":"15","key":"1174_CR41","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2016-09-741629","volume":"129","author":"T. Asano","year":"2017","unstructured":"T. Asano, Y. Meguri, T. Yoshioka, Y. Kishi, M. Iwamoto, M. Nakamura et al., PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 129(15), 2186\u20132197 (2017, Apr 13)","journal-title":"Blood"},{"key":"1174_CR42","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3389\/fimmu.2019.01187","volume":"10","author":"K.A. Hogan","year":"2019","unstructured":"K.A. Hogan, C.C.S. Chini, E.N. Chini, The multi-faceted ecto-enzyme CD38: roles in Immunomodulation, cancer, aging, and metabolic diseases. Front. Immunol. 10, 1187 (2019)","journal-title":"Front Immunol"},{"issue":"3","key":"1174_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","volume":"128","author":"J. Krejcik","year":"2016","unstructured":"J. Krejcik, T. Casneuf, I.S. Nijhof, B. Verbist, J. Bald, T. Plesner et al., Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma. Blood. 128(3), 384\u2013394 (2016, Jul 21)","journal-title":"Blood"},{"issue":"5","key":"1174_CR44","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.coi.2013.09.003","volume":"25","author":"N.P. Restifo","year":"2013","unstructured":"N.P. Restifo, L. Gattinoni, Lineage relationship of effector and memory T cells. Curr. Opin. Immunol. 25(5), 556\u2013563 (2013, Oct)","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"1174_CR45","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1182\/blood-2002-11-3577","volume":"101","author":"J. Geginat","year":"2003","unstructured":"J. Geginat, A. Lanzavecchia, F. Sallusto, Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood. 101(11), 4260\u20134266 (2003, Jun 1)","journal-title":"Blood"},{"issue":"25","key":"1174_CR46","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","volume":"353","author":"F. Pag\u00e8s","year":"2005","unstructured":"F. Pag\u00e8s, A. Berger, M. Camus, F. Sanchez-Cabo, A. Costes, R. Molidor et al., Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med. 353(25), 2654\u20132666 (2005, Dec 22)","journal-title":"N Engl J Med"},{"issue":"5","key":"1174_CR47","doi-asserted-by":"publisher","first-page":"813","DOI":"10.5858\/2008-132-813-ISOBBM","volume":"132","author":"X. Han","year":"2008","unstructured":"X. Han, J.L. Jorgensen, A. Brahmandam, E. Schlette, Y.O. Huh, Y. Shi et al., Immunophenotypic study of basophils by multiparameter flow cytometry. Archives. Pathol. Lab. Med. 132(5), 813\u2013819 (2008, May 1)","journal-title":"Archives Pathol Lab Med"},{"issue":"5","key":"1174_CR48","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3390\/ijms22052424","volume":"22","author":"M. Burns","year":"2021","unstructured":"M. Burns, L. Ostendorf, R. Biesen, A. Gr\u00fctzkau, F. Hiepe, H.E. Mei et al., Dysregulated CD38 expression on peripheral blood immune cell subsets in SLE. IJMS. 22(5), 2424 (2021, Feb 28)","journal-title":"IJMS"},{"issue":"5","key":"1174_CR49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1182\/blood-2018-05-850073","volume":"132","author":"C.A. Tormey","year":"2018","unstructured":"C.A. Tormey, A.J. Siddon, Morphology and flow cytometry of atypical basophils. Blood. 132(5), 552\u2013552 (2018, Aug 2)","journal-title":"Blood"},{"key":"1174_CR50","doi-asserted-by":"crossref","unstructured":"K. Masuda, A. Kornberg, J. Miller, S. Lin, N. Suek, T. Botella et al., Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer. JCI. Insight. 7(7), e154646 (2022, Apr 8)","DOI":"10.1172\/jci.insight.154646"},{"issue":"4","key":"1174_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/cells14040309","volume":"14","author":"L. Lin","year":"2025","unstructured":"L. Lin, G. Roccuzzo, Y. Yakymiv, S. Marchisio, E. Ortolan, A. Funaro et al., The CD39\/CD73\/Adenosine and NAD\/CD38\/CD203a\/CD73 axis in cutaneous T-Cell lymphomas. Cells. 14(4), 309 (2025, Feb 19)","journal-title":"Cells"},{"key":"1174_CR52","doi-asserted-by":"crossref","unstructured":"I. Sarkar, D. Basak, P. Ghosh, A. Gautam, A. Bhoumik, P. Singh et al., CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor. Sci. Adv. 11(12), eadt 2117 (2025, Mar 21)","DOI":"10.1126\/sciadv.adt2117"},{"issue":"10","key":"1174_CR53","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L. Gattinoni","year":"2011","unstructured":"L. Gattinoni, E. Lugli, Y. Ji, Z. Pos, C.M. Paulos, M.F. Quigley et al., A human memory T cell subset with stem cell-like properties. Nat. Med. 17(10), 1290\u20131297 (2011, Oct)","journal-title":"Nat Med"},{"issue":"1","key":"1174_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nprot.2012.143","volume":"8","author":"E. Lugli","year":"2013","unstructured":"E. Lugli, L. Gattinoni, A. Roberto, D. Mavilio, D.A. Price, N.P. Restifo et al., Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat. Protoc. 8(1), 33\u201342 (2013, Jan)","journal-title":"Nat Protoc"},{"key":"1174_CR55","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2147\/IJGM.S411122","volume":"16","author":"J. Ding","year":"2023","unstructured":"J. Ding, H. Wang, R. Hou, Y. Shi, H. Fan, Y. Li et al., Total T cell density and expression of T memory stem cell markers are associated with better prognosis in colon cancer. IJGM. 16, 2285\u20132294 (2023, Jun)","journal-title":"IJGM"},{"key":"1174_CR56","doi-asserted-by":"publisher","first-page":"701738","DOI":"10.3389\/fonc.2021.701738","volume":"11","author":"Y. Lu","year":"2021","unstructured":"Y. Lu, Q. Zhang, L. Zhang, CD4+ memory stem T cell in peripheral blood: a promising immune index for early screening and auxiliary diagnosis of colorectal cancer. Front. Oncol. 11, 701738 (2021, Jul 13)","journal-title":"Front Oncol"},{"issue":"1","key":"1174_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.0300-9475.2001.01019.x","volume":"55","author":"X.-B. Wang","year":"2002","unstructured":"X.-B. Wang, R. Giscombe, Z. Yan, T. Heiden, D. Xu, A.K. Lefvert, Expression of CTLA-4 by human monocytes. Scand. J. Immunol. 55(1), 53\u201360 (2002, Jan)","journal-title":"Scand J Immunol"},{"key":"1174_CR58","doi-asserted-by":"publisher","first-page":"608024","DOI":"10.3389\/fimmu.2020.608024","volume":"11","author":"D. Oyewole-Said","year":"2020","unstructured":"D. Oyewole-Said, V. Konduri, J. Vazquez-Perez, S.A. Weldon, J.M. Levitt, W.K. Decker, Beyond T-Cells: functional characterization of CTLA-4 expression in immune and non-immune cell types. Front. Immunol. 11, 608024 (2020, Dec 15)","journal-title":"Front Immunol"},{"key":"1174_CR59","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3389\/fimmu.2018.01838","volume":"9","author":"M. Terabe","year":"2018","unstructured":"M. Terabe, J.A. Berzofsky, Tissue-specific roles of NKT cells in tumor immunity. Front. Immunol. 9, 1838 (2018)","journal-title":"Front Immunol"},{"issue":"1","key":"1174_CR60","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s42003-025-08872-5","volume":"8","author":"M. Papanastasatou","year":"2025","unstructured":"M. Papanastasatou, M. Gioulbasani, E. Nakou, A. Galaras, T. Rubio-Tom\u00e1s, I. Talianidis et al., Dual regulatory role of natural killer T cells during development of hepatocellular carcinoma. Commun. Biol. 8(1), 1478 (2025, Oct 20)","journal-title":"Commun Biol"},{"issue":"9","key":"1174_CR61","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1002\/eji.200636075","volume":"36","author":"A.V. Gorbachev","year":"2006","unstructured":"A.V. Gorbachev, R.L. Fairchild, Activated NKT cells increase dendritic cell migration and enhance CD8+ T cell responses in the skin. Eur. J. Immunol. 36(9), 2494\u20132503 (2006, Sep)","journal-title":"Eur J Immunol"},{"issue":"14","key":"1174_CR62","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.3748\/wjg.v20.i14.3738","volume":"20","author":"S. Pernot","year":"2014","unstructured":"S. Pernot, M. Terme, T. Voron, O. Colussi, E. Marcheteau, E. Tartour et al., Colorectal cancer and immunity: what we know and perspectives. World. J. Gastroenterol. 20(14), 3738\u20133750 (2014, Apr 14)","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1174_CR63","doi-asserted-by":"publisher","first-page":"2009666","DOI":"10.1080\/2162402X.2021.2009666","volume":"11","author":"J. Burks","year":"2022","unstructured":"J. Burks, P.B. Olkhanud, J.A. Berzofsky, The role of NKT cells in gastrointestinal cancers. OncoImmunology. 11(1), 2009666 (2022, Dec 31)","journal-title":"OncoImmunology"},{"key":"1174_CR64","doi-asserted-by":"crossref","unstructured":"K. Cao, X. Wang, H. Wang, C. Xu, A. Ma, Y. Zhang et al., Phenotypic and functional exhaustion of circulating CD3+ CD56+ NKT-like cells in colorectal cancer patients. Faseb. J. 38(5), e23525 (2024, Mar 15)","DOI":"10.1096\/fj.202301743R"},{"issue":"5","key":"1174_CR65","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s11357-012-9488-5","volume":"35","author":"S. Buffa","year":"2013","unstructured":"S. Buffa, M. Pellican\u00f2, M. Bulati, A. Martorana, D. Goldeck, C. Caruso et al., A novel B cell population revealed by a CD38\/CD24 gating strategy: CD38\u2212CD24\u2212 B cells in centenarian offspring and elderly people. AGE. 35(5), 2009\u20132024 (2013, Oct)","journal-title":"AGE"},{"issue":"1","key":"1174_CR66","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F. Sallusto","year":"2004","unstructured":"F. Sallusto, J. Geginat, A. Lanzavecchia, Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22(1), 745\u2013763 (2004, Apr 1)","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1174_CR67","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4049\/jimmunol.1601102","volume":"198","author":"R.M. Rodriguez","year":"2017","unstructured":"R.M. Rodriguez, B. Suarez-Alvarez, J.L. Lav\u00edn, D. Mos\u00e9n-Ansorena, A. Baraga\u00f1o Raneros, L. M\u00e1rquez-Kisinousky et al., Epigenetic networks regulate the transcriptional program in memory and terminally differentiated CD8+ T cells. The. J. Immunol. 198(2), 937\u2013949 (2017, Jan 15)","journal-title":"The J Immunol"},{"key":"1174_CR68","doi-asserted-by":"publisher","first-page":"1284293","DOI":"10.3389\/fimmu.2023.1284293","volume":"14","author":"L. Guo","year":"2023","unstructured":"L. Guo, X. Liu, X. Su, The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease. Front. Immunol. 14, 1284293 (2023, Oct 12)","journal-title":"Front Immunol"},{"issue":"1","key":"1174_CR69","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4049\/jimmunol.1701153","volume":"202","author":"Y.E. Bar-Ephraim","year":"2019","unstructured":"Y.E. Bar-Ephraim, J.J. Koning, E. Burniol Ruiz, T. Konijn, V.P. Mourits, K.A. Lakeman et al., CD62L is a functional and phenotypic Marker for circulating innate lymphoid cell precursors. The. J. Immunol. 202(1), 171\u2013182 (2019, Jan 1)","journal-title":"The J Immunol"},{"key":"1174_CR70","doi-asserted-by":"crossref","unstructured":"E. Kokkinou, R.V. Pandey, L. Mazzurana, I. Gutierrez-Perez, C.A. Tibbitt, W. Weigel et al., CD45RA+ CD62L\u2212 ILCs in human tissues represent a quiescent local reservoir for the generation of differentiated ILCs. Sci. Immunol. 7(70), eabj 8301 (2022, Apr 15)","DOI":"10.1126\/sciimmunol.abj8301"},{"issue":"10","key":"1174_CR71","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/imcb.12387","volume":"98","author":"O. Lamiable","year":"2020","unstructured":"O. Lamiable, J.U. Mayer, L. Munoz-Erazo, F. Ronchese, Dendritic cells in Th2 immune responses and allergic sensitization. Immunol Cell. Biol. 98(10), 807\u2013818 (2020, Nov)","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"1174_CR72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2024.12.005","volume":"46","author":"B. Le\u00f3n","year":"2025","unstructured":"B. Le\u00f3n, Type 2 conventional dendritic cell functional heterogeneity: ontogenically committed or environmentally plastic? Trends. Immunol. 46(2), 104\u2013120 (2025, Feb)","journal-title":"Trends Immunol."},{"issue":"1","key":"1174_CR73","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12957-019-1621-9","volume":"17","author":"Y. Zhao","year":"2019","unstructured":"Y. Zhao, X. Ge, J. He, Y. Cheng, Z. Wang, J. Wang et al., The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis. World. J Surg. Oncol. 17(1), 85 (2019, May 22)","journal-title":"World J Surg Oncol"},{"issue":"5795","key":"1174_CR74","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J. Galon","year":"2006","unstructured":"J. Galon, A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pag\u00e8s et al., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 313(5795), 1960\u20131964 (2006, Sep 29)","journal-title":"Science"},{"issue":"1","key":"1174_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41540-025-00513-1","volume":"11","author":"C. Li","year":"2025","unstructured":"C. Li, Y. Wei, J. Lei, Quantitative cancer-immunity cycle modeling for predicting disease progression in advanced metastatic colorectal cancer. npj. Syst. Biol. Appl. 11(1), 33 (2025, Apr 13)","journal-title":"npj Syst Biol Appl"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01174-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01174-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:06:10Z","timestamp":1771977970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01174-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01174-w","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written and informed consent was obtained from all participants. The study protocol followed the principles of the Declaration of Helsinki and was granted by the La Paz University Hospital Ethics Committee (HULP-PI-1958). Prior to enrolment, all participants were informed about the purpose and procedures of the study and provided written informed consent. To guarantee the confidentiality of the patient data, the information was anonymised. All procedures undertaken as part of the study were in accordance with the relevant national and institutional ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"All authors have given their approval for the publication of this final version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The present study is limited by its small sample size (\n                      n\n                      \u2009=\u200916), which may restrict statistical power and increases the risk of false discoveries when analysing a high-dimensional dataset comprising over 900 immune features. Likewise, the number of individuals suffering from metastases, as well as of survival events, might be inadequate to support robust multivariable survival modelling, and results from these analyses should be interpreted with caution. Moreover, although efforts were made to minimise technical variability through consistent sample processing and acquisition, batch effects cannot be entirely excluded. In view of these considerations, the identified immune alterations should be regarded as hypothesis-generating and require validation in larger independent cohorts to confirm their reproducibility and clinical relevance. Furthermore, complementary functional studies, encompassing cytokine production assays, assessment of immune cell cytotoxicity, and the analysis of checkpoint modulation, will be necessary to elucidate the biological significance of the observed phenotypic associations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Limitations of the study"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}